Filing Details
- Accession Number:
- 0001235802-17-000140
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-14 11:35:13
- Reporting Period:
- 2017-08-10
- Filing Date:
- 2017-08-14
- Accepted Time:
- 2017-08-14 11:35:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1138776 | Aevi Genomic Medicine Inc. | GNMX | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1181073 | R Philip Harper | 1850 Rose Cottage Lane Malvern PA 19355 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-08-10 | 20,470 | $1.19 | 4,865,683 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 220,000 | Indirect | By wife |
Footnotes
- The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.175 to $1.20, inclusive. The reporting person undertakes to provide to the issuer, its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.